HIGHLIGHTS
- who: Adrià Duran et al. from the Biochemistry and Molecular Biology Unit, Department of Biology, University of Girona, Girona, Spain have published the research: Characterization of Mesothelin Glycosylation in Pancreatic Cancer: Decreased Core Fucosylated Glycoforms in Pancreatic Cancer Patients’ Sera, in the Journal: Biomedicines 2022, 10, 1942. of 10/08/2022
- what: The authors aimed to characterize MSLN glycans from PaC cells and serum samples to assess their potential usefulness as PaC biomarkers. The authors focused on the analysis of the MSLN glycan determinants previously described by N-glycan sequencing, in particular sialylation, fucosylation, antenna . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.